SC 13G

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

October 18, 2004

Accession Number

0001104659-04-030751

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →